Background Cholinesterase inhibitors produce small improvements in cognitive and global assessments in Alzheimer's disease. We aimed to determine whether donepezil produces worthwhile improvements in disability, dependency, behavioural and psychological symptoms, carers? psychological wellbeing, or delay in institutionalisation. If so, which patients benefit, from what dose, and for how long?...